IMA vs MAS · rev $9.2M vs P/E 18, rev $7.83B
ImageneBio, Inc. (IMA) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported MAS revenue for 2024-12-31 was $7.83B. Net income was $874.0M. Revenue was down 1.7% from 2023-12-31 to 2024-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
IMA currently screens at market cap $64.7M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the IMA and MAS stock pages for the full models.
Not investment advice.